- A Double-Blind Comparison of Moxonidine and Atenolol in the Management of Patients with Mild-to-Moderate Hypertension - (https://journals.lww.com/cardiovascularpharm/abstract/1992/20004/a_double_blind_comparison_of_moxonidine_and.10.aspx)
- Moxonidine for Prevention of Post-ablation AFib Recurrences - (https://clinicaltrials.gov/ct2/show/NCT01791699 )
- The Difficulties in Antihypertensive Drug Prescription During Lactation: Is the Information Consistent? - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683560/ )
- Moxonidine treatment of hypertensive patients with advanced renal failure - (https://pubmed.ncbi.nlm.nih.gov/12923404/ )
- Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study - (https://pubmed.ncbi.nlm.nih.gov/15269705/ )
Essential hypertension is also known as primary hypertension or idiopathic hypertension which means it does not have an identifiable cause.
It is used to control the raised blood pressure mainly when first and second line therapy drugs such as beta-blockers, thiazides, ACE inhibitors and calcium channel blockers fail to control blood pressure or are contraindicated or not tolerated.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Moxovas (0.3mg) - Macleods Pharmaceuticals Ltd. (Procare Aht)
Moxovas (0.3mg) Film coated tablet
Generic : Moxonidine
Substitute/Alternative Medication to Moxovas (0.3mg)
When is Moxovas (0.3mg) prescribed?
It is prescribed for -